免疫チェックポイント阻害剤の市場:種類(CTLA-4阻害剤、PD-1阻害剤、PD-L1阻害剤)、流通チャネル(病院薬局、小売薬局、オンライン薬局)、用途(肺がん、膀胱がん、メラノーマ、大腸がん、ホジキンリンパ腫、その他)、地域 2023-2028Immune Checkpoint Inhibitors Market by Type (CTLA-4 Inhibitor, PD-1 Inhibitor, PD-L1 Inhibitor), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Lung Cancer, Bladder Cancer, Melanoma, Colorectal Cancer, Hodgkin Lymphoma, and Others), and Region 2023-2028 市場の概要 免疫チェックポイント阻害剤の世界市場規模は、2022年に366億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に17.19%の成長率(CAGR)を示し、2028年までに973億米ドルに達すると... もっと見る
サマリー市場の概要免疫チェックポイント阻害剤の世界市場規模は、2022年に366億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に17.19%の成長率(CAGR)を示し、2028年までに973億米ドルに達すると予測しています。様々な癌の有病率の上昇、呼吸器疾患の増加、個別化された医薬品への嗜好の高まりなどが、市場を牽引する主要な要因の一つです。 免疫チェックポイント阻害剤は、T細胞などの免疫系細胞やがん細胞が作る特定のタンパク質を阻害することにより、がんの治療に利用される薬剤です。単独で、あるいは化学療法や放射線療法など他のがん治療と組み合わせて使用することで、治療効果を高めることができます。また、病気の症状を軽減し、生存期間を延ばすことで、がん患者さんのQOL(生活の質)を高めることに貢献します。免疫チェックポイント阻害剤は、免疫系の特定の経路を標的とするため、がん治療においてより的を絞ったアプローチが可能となります。また、これらの阻害剤は、従来の化学療法と比較して、副作用が少なく、患者さんへの耐性が高いという毒性プロファイルを持っています。現在、がん細胞内の特定の遺伝子変異を同定することができる次世代シーケンサー技術の利用が増加しており、世界中で免疫チェックポイント阻害剤の需要が高まっています。 免疫チェックポイント阻害剤の市場動向: メラノーマ、肝臓、腎臓、胃などの様々な癌の急増は、免疫チェックポイント阻害剤の世界的な需要を促進する主要な要因の一つとなっています。さらに、このような深刻ながんを発症しやすい高齢者人口の増加や、肥満の有病率の上昇が、市場の成長に好影響を与えています。さらに、アルコール飲料やタバコの消費量の増加により、呼吸器疾患の発生が増加しています。さらに、不健康な食習慣や座りっぱなしの生活習慣により、体重に関連した健康上の懸念が増加していることも、市場にプラスの影響を与えています。これとは別に、さまざまな遺伝性疾患や生活習慣病の急増、がんの早期診断と治療の利点に関する個人や医療従事者の意識の高まりが、市場の成長を後押ししています。さらに、製薬会社による臨床試験数の拡大、個別化医療や新世代の医薬品・製剤への嗜好の高まりも、市場の成長を後押ししています。このほか、製品ポートフォリオを拡大し競争力を高めるために、戦略的提携や新製品開発に注力する大手企業の動きが活発化していることも、市場に明るい展望を生み出しています。さらに、医療インフラや診断技術の大幅な向上が、市場の成長を強化すると予想されています。 主要な市場セグメント: IMARC Groupは、世界の免疫チェックポイント阻害剤市場の各セグメントにおける主要動向の分析、および2023年から2028年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、市場をタイプ、流通チャネル、アプリケーションに基づき分類しています。 タイプのインサイトです: CTLA-4 インヒビター PD-1インヒビター PD-L1インヒビター 本レポートでは、免疫チェックポイント阻害剤市場をタイプ別に詳細に分解・分析しています。これには、CTLA-4阻害剤、PD-1阻害剤、PD-L1阻害剤が含まれます。それによると、PD-1阻害剤は最大のセグメントを占めています。 ディストリビューション・チャネル・インサイト 病院内薬局 小売薬局 オンラインファーマシーズ また、免疫チェックポイント阻害剤市場について、流通チャネルに基づく詳細な分類と分析も行っています。これには、病院薬局、小売薬局、オンライン薬局が含まれます。報告書によると、病院薬局が最大の市場シェアを占めています。 アプリケーションインサイト 肺がん 膀胱がん(Bladder Cancer メラノーマ 大腸がん(Colorectal Cancer ホジキンリンパ腫 その他 本レポートでは、免疫チェックポイント阻害剤市場を用途別に詳細に分解・分析しています。これには、肺がん、膀胱がん、メラノーマ、結腸直腸がん、ホジキンリンパ腫、その他が含まれます。それによると、肺がんが最大のセグメントを占めています。 地域別インサイト 北アメリカ ユーエスエー カナダ アジア太平洋 中国 日本 インド 南朝鮮 オーストラリア インドネシア その他 ヨーロッパ ドイツ フランス イギリス イタリア スペイン ロシア その他 ラテンアメリカ ブラジル メキシコ その他 中近東・アフリカ また、北米(米国、カナダ)、アジア太平洋(中国、日本、インド、韓国、オーストラリア、インドネシア、その他)、欧州(ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他)、中南米(ブラジル、メキシコ、その他)、中東・アフリカの主要地域市場すべてについて包括的に分析しています。それによると、免疫チェックポイント阻害剤の市場は、北米が最大でした。北米の免疫チェックポイント阻害剤市場を牽引する要因としては、高齢化人口の増加、確立された医療インフラの存在、研究開発(R&D)活動の活発化などが挙げられます。 競合の状況: また、世界の免疫チェックポイント阻害剤市場における競争環境についても包括的な分析を行っています。市場構造、主要プレイヤーによる市場シェア、プレイヤーのポジショニング、トップの勝利戦略、競合ダッシュボード、企業評価象限などの競争分析が、本レポートでカバーされています。また、すべての主要企業の詳細なプロフィールが提供されています。対象となる企業には、AstraZeneca plc、Bristol-Myers Squibb Company、GSK plc、Merck & Co.Inc.、小野薬品工業Inc.Ltd.、Pfizer Inc.、Regeneron Pharmaceuticals Inc.、Seagen Inc.などです。なお、これは企業の一部のリストであり、完全なリストは報告書に記載されています。 本レポートで回答した主な質問 免疫チェックポイント阻害剤の世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか? 世界の免疫チェックポイント阻害剤市場における推進要因、阻害要因、機会は何か? 各駆動因子、阻害因子、機会が世界の免疫チェックポイント阻害剤市場に与える影響は? 主要な地域市場とは? 最も魅力的な免疫チェックポイント阻害剤市場を代表する国はどこか? タイプ別の市場の内訳は? 免疫チェックポイント阻害剤市場において最も魅力的なタイプは何か? 販売チャネルに基づく市場の内訳は? 免疫チェックポイント阻害剤市場において最も魅力的な流通チャネルはどこか? アプリケーションに基づく市場の内訳は? 免疫チェックポイント阻害剤市場において最も魅力的なアプリケーションは何か? 世界の免疫チェックポイント阻害剤市場の競争構造は? 免疫チェックポイント阻害剤の世界市場における主要なプレイヤー/企業はどこか? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Immune Checkpoint Inhibitors Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Type 6.1 CTLA-4 Inhibitor 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 PD-1 Inhibitor 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 PD-L1 Inhibitor 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Distribution Channel 7.1 Hospital Pharmacies 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Retail Pharmacies 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Online Pharmacies 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Application 8.1 Lung Cancer 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Bladder Cancer 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Melanoma 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Colorectal Cancer 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Hodgkin Lymphoma 8.5.1 Market Trends 8.5.2 Market Forecast 8.6 Others 8.6.1 Market Trends 8.6.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 Drivers, Restraints, and Opportunities 10.1 Overview 10.2 Drivers 10.3 Restraints 10.4 Opportunities 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 AstraZeneca plc 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 Financials 14.3.1.4 SWOT Analysis 14.3.2 Bristol-Myers Squibb Company 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.2.4 SWOT Analysis 14.3.3 GSK plc 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.3.4 SWOT Analysis 14.3.4 Merck & Co. Inc. 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Ono Pharmaceutical Co. Ltd. 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.5.4 SWOT Analysis 14.3.6 Pfizer Inc. 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Regeneron Pharmaceuticals Inc. 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.7.4 SWOT Analysis 14.3.8 Seagen Inc. 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report. List of Figures Figure 1: Global: Immune Checkpoint Inhibitors Market: Major Drivers and Challenges Figure 2: Global: Immune Checkpoint Inhibitors Market: Sales Value (in Billion US$), 2017-2022 Figure 3: Global: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Billion US$), 2023-2028 Figure 4: Global: Immune Checkpoint Inhibitors Market: Breakup by Type (in %), 2022 Figure 5: Global: Immune Checkpoint Inhibitors Market: Breakup by Distribution Channel (in %), 2022 Figure 6: Global: Immune Checkpoint Inhibitors Market: Breakup by Application (in %), 2022 Figure 7: Global: Immune Checkpoint Inhibitors Market: Breakup by Region (in %), 2022 Figure 8: Global: Immune Checkpoint Inhibitors (CTLA-4 Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022 Figure 9: Global: Immune Checkpoint Inhibitors (CTLA-4 Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 10: Global: Immune Checkpoint Inhibitors (PD-1 Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022 Figure 11: Global: Immune Checkpoint Inhibitors (PD-1 Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 12: Global: Immune Checkpoint Inhibitors (PD-L1 Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022 Figure 13: Global: Immune Checkpoint Inhibitors (PD-L1 Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 14: Global: Immune Checkpoint Inhibitors (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022 Figure 15: Global: Immune Checkpoint Inhibitors (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 16: Global: Immune Checkpoint Inhibitors (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022 Figure 17: Global: Immune Checkpoint Inhibitors (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 18: Global: Immune Checkpoint Inhibitors (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022 Figure 19: Global: Immune Checkpoint Inhibitors (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 20: Global: Immune Checkpoint Inhibitors (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022 Figure 21: Global: Immune Checkpoint Inhibitors (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 22: Global: Immune Checkpoint Inhibitors (Bladder Cancer) Market: Sales Value (in Million US$), 2017 & 2022 Figure 23: Global: Immune Checkpoint Inhibitors (Bladder Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 24: Global: Immune Checkpoint Inhibitors (Melanoma) Market: Sales Value (in Million US$), 2017 & 2022 Figure 25: Global: Immune Checkpoint Inhibitors (Melanoma) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 26: Global: Immune Checkpoint Inhibitors (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022 Figure 27: Global: Immune Checkpoint Inhibitors (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 28: Global: Immune Checkpoint Inhibitors (Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2017 & 2022 Figure 29: Global: Immune Checkpoint Inhibitors (Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 30: Global: Immune Checkpoint Inhibitors (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022 Figure 31: Global: Immune Checkpoint Inhibitors (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 32: North America: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 33: North America: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 34: United States: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 35: United States: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 36: Canada: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 37: Canada: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 38: Asia-Pacific: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 39: Asia-Pacific: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 40: China: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 41: China: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 42: Japan: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 43: Japan: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 44: India: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 45: India: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 46: South Korea: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 47: South Korea: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 48: Australia: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 49: Australia: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 50: Indonesia: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 51: Indonesia: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 52: Others: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 53: Others: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 54: Europe: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 55: Europe: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 56: Germany: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 57: Germany: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 58: France: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 59: France: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 60: United Kingdom: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 61: United Kingdom: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 62: Italy: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 63: Italy: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 64: Spain: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 65: Spain: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 66: Russia: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 67: Russia: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 68: Others: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 69: Others: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 70: Latin America: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 71: Latin America: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 72: Brazil: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 73: Brazil: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 74: Mexico: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 75: Mexico: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 76: Others: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 77: Others: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 78: Middle East and Africa: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 79: Middle East and Africa: Immune Checkpoint Inhibitors Market: Breakup by Country (in %), 2022 Figure 80: Middle East and Africa: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 81: Global: Immune Checkpoint Inhibitors Industry: Drivers, Restraints, and Opportunities Figure 82: Global: Immune Checkpoint Inhibitors Industry: Value Chain Analysis Figure 83: Global: Immune Checkpoint Inhibitors Industry: Porter's Five Forces Analysis List of Tables Table 1: Global: Immune Checkpoint Inhibitors Market: Key Industry Highlights, 2022 & 2028 Table 2: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Type (in Million US$), 2023-2028 Table 3: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028 Table 4: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Application (in Million US$), 2023-2028 Table 5: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Region (in Million US$), 2023-2028 Table 6: Global: Immune Checkpoint Inhibitors Market: Competitive Structure Table 7: Global: Immune Checkpoint Inhibitors Market: Key Players
SummaryMarket Overview: Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Immune Checkpoint Inhibitors Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Type 6.1 CTLA-4 Inhibitor 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 PD-1 Inhibitor 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 PD-L1 Inhibitor 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Distribution Channel 7.1 Hospital Pharmacies 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Retail Pharmacies 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Online Pharmacies 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Application 8.1 Lung Cancer 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Bladder Cancer 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Melanoma 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Colorectal Cancer 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Hodgkin Lymphoma 8.5.1 Market Trends 8.5.2 Market Forecast 8.6 Others 8.6.1 Market Trends 8.6.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 Drivers, Restraints, and Opportunities 10.1 Overview 10.2 Drivers 10.3 Restraints 10.4 Opportunities 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 AstraZeneca plc 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 Financials 14.3.1.4 SWOT Analysis 14.3.2 Bristol-Myers Squibb Company 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.2.4 SWOT Analysis 14.3.3 GSK plc 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.3.4 SWOT Analysis 14.3.4 Merck & Co. Inc. 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Ono Pharmaceutical Co. Ltd. 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.5.4 SWOT Analysis 14.3.6 Pfizer Inc. 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Regeneron Pharmaceuticals Inc. 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.7.4 SWOT Analysis 14.3.8 Seagen Inc. 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report. List of Figures Figure 1: Global: Immune Checkpoint Inhibitors Market: Major Drivers and Challenges Figure 2: Global: Immune Checkpoint Inhibitors Market: Sales Value (in Billion US$), 2017-2022 Figure 3: Global: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Billion US$), 2023-2028 Figure 4: Global: Immune Checkpoint Inhibitors Market: Breakup by Type (in %), 2022 Figure 5: Global: Immune Checkpoint Inhibitors Market: Breakup by Distribution Channel (in %), 2022 Figure 6: Global: Immune Checkpoint Inhibitors Market: Breakup by Application (in %), 2022 Figure 7: Global: Immune Checkpoint Inhibitors Market: Breakup by Region (in %), 2022 Figure 8: Global: Immune Checkpoint Inhibitors (CTLA-4 Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022 Figure 9: Global: Immune Checkpoint Inhibitors (CTLA-4 Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 10: Global: Immune Checkpoint Inhibitors (PD-1 Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022 Figure 11: Global: Immune Checkpoint Inhibitors (PD-1 Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 12: Global: Immune Checkpoint Inhibitors (PD-L1 Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022 Figure 13: Global: Immune Checkpoint Inhibitors (PD-L1 Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 14: Global: Immune Checkpoint Inhibitors (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022 Figure 15: Global: Immune Checkpoint Inhibitors (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 16: Global: Immune Checkpoint Inhibitors (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022 Figure 17: Global: Immune Checkpoint Inhibitors (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 18: Global: Immune Checkpoint Inhibitors (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022 Figure 19: Global: Immune Checkpoint Inhibitors (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 20: Global: Immune Checkpoint Inhibitors (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022 Figure 21: Global: Immune Checkpoint Inhibitors (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 22: Global: Immune Checkpoint Inhibitors (Bladder Cancer) Market: Sales Value (in Million US$), 2017 & 2022 Figure 23: Global: Immune Checkpoint Inhibitors (Bladder Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 24: Global: Immune Checkpoint Inhibitors (Melanoma) Market: Sales Value (in Million US$), 2017 & 2022 Figure 25: Global: Immune Checkpoint Inhibitors (Melanoma) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 26: Global: Immune Checkpoint Inhibitors (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022 Figure 27: Global: Immune Checkpoint Inhibitors (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 28: Global: Immune Checkpoint Inhibitors (Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2017 & 2022 Figure 29: Global: Immune Checkpoint Inhibitors (Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 30: Global: Immune Checkpoint Inhibitors (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022 Figure 31: Global: Immune Checkpoint Inhibitors (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 32: North America: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 33: North America: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 34: United States: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 35: United States: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 36: Canada: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 37: Canada: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 38: Asia-Pacific: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 39: Asia-Pacific: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 40: China: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 41: China: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 42: Japan: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 43: Japan: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 44: India: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 45: India: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 46: South Korea: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 47: South Korea: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 48: Australia: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 49: Australia: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 50: Indonesia: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 51: Indonesia: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 52: Others: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 53: Others: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 54: Europe: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 55: Europe: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 56: Germany: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 57: Germany: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 58: France: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 59: France: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 60: United Kingdom: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 61: United Kingdom: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 62: Italy: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 63: Italy: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 64: Spain: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 65: Spain: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 66: Russia: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 67: Russia: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 68: Others: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 69: Others: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 70: Latin America: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 71: Latin America: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 72: Brazil: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 73: Brazil: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 74: Mexico: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 75: Mexico: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 76: Others: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 77: Others: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 78: Middle East and Africa: Immune Checkpoint Inhibitors Market: Sales Value (in Million US$), 2017 & 2022 Figure 79: Middle East and Africa: Immune Checkpoint Inhibitors Market: Breakup by Country (in %), 2022 Figure 80: Middle East and Africa: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 81: Global: Immune Checkpoint Inhibitors Industry: Drivers, Restraints, and Opportunities Figure 82: Global: Immune Checkpoint Inhibitors Industry: Value Chain Analysis Figure 83: Global: Immune Checkpoint Inhibitors Industry: Porter's Five Forces Analysis List of Tables Table 1: Global: Immune Checkpoint Inhibitors Market: Key Industry Highlights, 2022 & 2028 Table 2: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Type (in Million US$), 2023-2028 Table 3: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028 Table 4: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Application (in Million US$), 2023-2028 Table 5: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Region (in Million US$), 2023-2028 Table 6: Global: Immune Checkpoint Inhibitors Market: Competitive Structure Table 7: Global: Immune Checkpoint Inhibitors Market: Key Players
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
IMARC Services Private Limited.社の医療分野での最新刊レポート
本レポートと同じKEY WORD(immune)の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|